SAGILITY LIMITED received a disclosure from its promoter Sagility B.V. under Regulation 31(4) of the SEBI Takeover Regulations, 2011. The filing, dated April 7, 2026, confirms that Sagility B.V. created no new encumbrance on Sagility Limited shares during the financial year ended March 31, 2026.
Sagility B.V. based in Amsterdam, Netherlands, submitted the disclosure to the National Stock Exchange of India Limited and BSE Limited. The promoter declared on behalf of itself and all persons acting in concert that no encumbrance was made directly or indirectly during the financial year ended March 31, 2026 other than those already reported in earlier filings within the period.
Sagility B.V. confirmed that Sagility's promoter group did not add any fresh share pledges in fiscal 2025-26 beyond those already disclosed in prior filings. The Regulation 31(4) filing covers encumbrances including pledges and hypothecation on shares held by the promoter group of Sagility Limited.
Sagility Limited shares are listed on the NSE and BSE. Sagility provides healthcare and insurance business process management services and is headquartered in Bengaluru, Karnataka. The disclosure was addressed to Sagility Limited's audit committee and was filed with the National Stock Exchange of India Limited and BSE Limited through their listing departments.
The disclosure was signed by Vistra Management Services (Netherlands) B.V. and T. Bogaards as directors of Sagility B.V. The promoter entity is incorporated in the Netherlands with its registered office at Herikerbergweg 84, 1101 CM Amsterdam. Sagility B.V. is the promoter of Sagility Limited.
Disclaimer: This article is based on company filings submitted to the Bombay Stock Exchange (BSE) and National Stock Exchange of India (NSE) and is for informational purposes only. It does not constitute investment advice or a recommendation. Investors should conduct their own research and consult a qualified financial advisor before making investment decisions.